The increasing product launches and approvals are expected to drive the market growth over the forecast period.
For instance, in April 2021, Chemence Medical, a world leader in medical cyanoacrylate devices and products, announced that the company had received the U.S. FDA 510(k) approval for its redesigned exofin fusion skin closure system. Exofin fusion combines a self-adhering flexible mesh strip and fast curing 2-octyl cyanoacrylate topical adhesive to close and seal incisions while forming an immediate barrier to protect against infections.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients